Applied DNA Sciences believes it regained Nasdaq minimum equity compliance after $10.8M offering

BNB PLUS CORP.

Received Nasdaq deficiency notice May 16, 2024 for stockholders' equity of -$175,385 vs. $2.5M minimum requirement.
Closed public offering May 29, 2024, raising approximately $10.8M in net proceeds from common stock and warrants.
Company now believes it meets Nasdaq Listing Rule 5550(b)(1) stockholders' equity requirement.
Nasdaq will continue monitoring; non-compliance at next periodic report may lead to delisting.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.